Search Results (72)

Background: Paramagnetic manganese (Mn(II)) has emerged as a promising alternative to gadolinium-based contrast agents (GBCAs) due to its favorable magnetic properties. Despite extensive research, no Mn-based agent has yet achieved clinical translation. Because free Mn(II) is toxic, macromolecular complexes incorporating stable macrocyclic DOTA chelators conjugated to polysaccharides may enhance coordination stability and improve the safety profile of Mn(II)-based contrast agents. Methods: Two chemical routes, maleimide- and ester-mediated, were evaluated for covalent coupling of DOTA-based macrocyclic ligands to the backbone of selected poly- and oligosaccharides. Subsequently, DOTA-modified carboxymethyldextran, aminodextran, and chitosan oligosaccharide were labeled with paramagnetic Mn(II) under mild conditions. ATR-FTIR confirmed the successful conjugation of DOTA chelators to the sugar backbone. The conjugates were further characterized by DLS, ICP-MS, and FPLC. In vitro relaxivity was measured at high field strength to evaluate MRI performance. In vivo contrast efficacy was first assessed using in ovo MRI in chicken embryos and subsequently evaluated by biodistribution studies in nude mice. Results: In vitro relaxivity studies demonstrated higher signal enhancement of the poly-/oligosaccharide-DOTA-Mn(II) conjugates compared with MnCl₂ and the clinical agent gadoteridol (ProHance^®). In ovo MRI showed persistent vascular enhancement up to 120 min, while in nude mice, contrast enhancement was observed in the liver, kidneys, and gallbladder 40 min post-injection. Conclusions: Mn(II)-tagged sugar-based imaging probes may offer a promising non-gadolinium alternative to GBCAs, with tunable biodistribution profiles depending on carrier molecular weight. Full article

Gadolinium-based contrast agents are widely used in clinical magnetic resonance imaging (MRI) due to their strong paramagnetic properties and ability to enhance image contrast. Despite their diagnostic value, concerns remain regarding gadolinium toxicity and long-term tissue retention, particularly for less stable linear chelates. In this study, we report preliminary results on a newly synthesized gadolinium-based compound (L-Gd), in which the Gd³⁺ ion is coordinated to a specific ligand designed to improve biocompatibility. To evaluate the feasibility of L-Gd encapsulation within human RBCs (hRBCs) for drug delivery, its biocompatibility and cellular interactions were thoroughly investigated. RBCs represent an attractive biomimetic carrier system capable of limiting the direct exposure of tissues to paramagnetic agents while potentially improving circulation time and safety. In vitro assays demonstrated that L-Gd maintains high compatibility with hRBCs within specific concentration ranges, showing no significant hemolysis or morphological alterations. Furthermore, preliminary encapsulation studies indicate that L-Gd can be successfully associated with RBCs, supporting the potential of this approach for contrast agent delivery. These findings suggest that RBC-mediated transport of gadolinium complexes may represent a promising strategy to reduce toxicity and mitigate gadolinium retention. Further investigations will focus on optimizing encapsulation efficiency, relaxometric properties, and in vivo behavior of the L-Gd system. Full article

Magnetic resonance imaging (MRI) is one of the most powerful non-invasive methods for cancer diagnostics. To enhance image contrast and, therefore, diagnostic accuracy, contrast agents (CAs) are widely used in clinics. For decades, the clinical standard has been metal-based CAs, primarily gadolinium- and manganese-based chelates, or iron oxide nanoparticles. However, metal-based CAs possess sub-effects, toxicity, and associated adverse health effects, such as nephrogenic systemic fibrosis. As an alternative, metal-free organic radical CAs (ORCAs), based on nitroxides, have been developed. ORCAs are widely used as primary ¹H-MRI agents and offer many advantages, including high biocompatibility, biodegradability, and easy functionalization. Attachment of nitroxides to natural or synthetic polymers enables the development of constructs with prolonged systemic circulation time and tumor-targeted delivery. Furthermore, MR-signal amplification can be achieved through physical hyperpolarization techniques, such as dynamic nuclear polarization (DNP) and Overhauser-enhanced MRI (OMRI), in which nitroxide radicals serve as hyperpolarizing agents, yielding signal enhancements. This review summarizes low-molecular-weight nitroxides, polymeric, and biomacromolecular platforms for ¹H-MRI, focusing on physicochemical properties, preclinical evidence in tumor imaging, and current limitations. One section highlights the use of nitroxides as hyperpolarizing agents for tumor metabolism analysis or OMRI. The review addresses ongoing challenges and outlines future perspectives for the clinical translation of ORCAs in cancer diagnostics. Full article

In clinical and preclinical magnetic resonance imaging (MRI), image quality is often limited by intrinsic tissue contrast, so paramagnetic agents are used to amplify relaxation differences and improve lesion detectability. Widely used gadolinium-based contrast agents present recognized drawbacks, stimulating interest in nanoscale platforms with tuneable magnetic and biological properties. This review provides a critical analysis on the use of metal-doped carbon nanodots (C-dots) as MRI contrast candidates. We briefly revisit MRI signal formation, spin–lattice ($T_1$) and spin–spin ($T_2$) relaxation, and relaxometric parameters $r_1$ and $r_2$ and outline how pulse-sequence choice favours $T_1$- or $T_2$-dominant agents. We compare approved small-molecule agents with nanostructured systems, highlighting unmet needs in safety, field-strength dependence, multimodality, and organ-specific imaging. A central focus is how nano- and molecular architectures of metal-doped carbon dots govern $r_1$ and $r_2$: the metal species and oxidation state, its location within the carbon matrix, surface chemistry and hydration, and the accessibility for proton and water exchange can shift performance toward $T_1$ or $T_2$. Engineered C-dots with controlled composition and metal dopants have proven to pair improved relaxivity with fluorescence, targeting ligands, or therapeutic payloads. Overall, metal-doped C-dots represent a flexible and potentially safer alternative to classical contrast agents; however, successful clinical translation and market uptake will still require standardized relaxometry at clinical field strengths, scalable and reproducible synthesis, and comprehensive in vivo safety and efficacy validation. Full article

Background/Objectives: First row transition metal ions have recently regained attention in coordination chemistry as alternatives to gadolinium-based paramagnetic contrast agents, motivated by emerging safety concerns associated with certain Gd³⁺-based contrast agents. In this study, we report the development of a novel homoleptic diketonate Fe³⁺ complex functionalized with biocompatible indole moieties. We investigate its potential as a paramagnetic relaxation agent by evaluating its ability to modulate the T₁ and T₂ relaxation times of water proton. Methods: Iron(III) tris-1,3-(1-methylindol-3-yl)propanedionate [Fe(BIP)₃] was synthesized via a thermal method from bis(1-methylindol-3-yl)-1,3-propanedione (HBIP) using Fe(ClO₄)₃∙6 H₂O as the metal source. The complex was characterized by UV-Vis, IR and NMR spectroscopy, differential scanning calorimetry–thermogravimetric analysis, and single-crystal X-ray diffraction. Fe(BIP)₃ aggregation behavior in aqueous environment, including size and morphology of aggregates, was investigated using dynamic light scattering and scanning electron microscopy. Incorporation of the aggregates into phospholipid vesicles was evaluated by fluorescence resonance energy transfer and fluorescence correlation spectroscopy. The paramagnetic properties of monomeric Fe(BIP)₃ were probed in solution by nuclear magnetic resonance recurring to the Evans bulk magnetization method. Results: The designed synthetic procedure successfully afforded Fe(BIP)₃, which was fully characterized by UV-Vis and IR spectroscopy, as well as single-crystal X-ray diffraction. Aqueous solutions of Fe(BIP)₃ spontaneously formed rice-grain-shaped nanoscale aggregates of hydrodynamic radius ≈ 30 nm. Incorporation of these aggregates into phospholipid vesicles enhanced their stability. The longitudinal r₁ and transverse r₂ relaxivities of Fe(BIP)₃ aggregates were assessed to be 1.92 and 52.3 mM⁻¹s⁻¹, respectively, revealing their potential as paramagnetic relaxation agents. Conclusions: Fe(BIP)₃ aggregates, stabilized through incorporation into phospholipid vesicles, demonstrate promising potential as novel paramagnetic relaxation agents in aqueous environments. Full article

Gadolinium-doped hydroxyapatite nanoparticles (HapGd NPs) have emerged as promising multifunctional platforms for biomedical applications due to their unique combination of biocompatibility, structural tunability, and magnetic responsiveness. In this work, HapGd nanoparticles were synthesized using a microwave-assisted method and subsequently functionalized with curcumin and folic acid to enhance therapeutic efficiency and selective targeting. The synthesized nanostructures were characterized using various techniques, including X-ray diffraction (XRD), transmission electron microscopy (TEM), Fourier-transform infrared spectroscopy (FTIR), thermogravimetric analysis (TGA), vibrating sample magnetometry (VSM), and relaxometry. Structural analyses revealed successful incorporation of Gd³⁺ ions into the Hap lattice, resulting in reduced unit cell volume and slight lattice distortion, while preserving the apatite crystalline framework. Surface functionalization with curcumin and folic acid was confirmed through spectroscopic characterization, demonstrating effective molecular attachment. Nuclear Magnetic Resonance (NMR) relaxation measurements indicated that Gd doping endowed paramagnetic behavior suitable for contrast enhancement in magnetic resonance imaging (MRI). Relaxometry studies revealed a strong linear correlation between 1/T₁ and the Gd³⁺ concentration, especially in the functionalized samples, with performance comparable to the commercial contrast agent Omniscan™. The developed HapGd-based nanoplatform exhibits integrated diagnostic and therapeutic potential, providing a foundation for future research in biomedical applications. Full article

Atherosclerosis remains a leading cause of cardiovascular mortality despite advances in pharmacological and interventional therapies. Current treatment approaches face limitations including systemic side effects, inadequate local drug delivery, and restenosis following vascular interventions. Gel-based technologies offer unique advantages through tunable mechanical properties, controlled degradation kinetics, high drug-loading capacity, and potential for stimuli-responsive therapeutic release. This review examines gel platforms across multiple scales and applications in atherosclerosis research and intervention. First, gel-based in vitro models are discussed. These include hydrogel matrices simulating plaque microenvironments, three-dimensional cellular culture platforms, and microfluidic organ-on-chip devices. These devices incorporate physiological flow to investigate disease mechanisms under controlled conditions. Second, therapeutic strategies are addressed through macroscopic gels for localized treatment. These encompass natural polymer-based, synthetic polymer-based, and composite formulations. Applications include stent coatings, adventitial injections, and catheter-delivered depots. Natural polymers often possess intrinsic biological activities including anti-inflammatory and immunomodulatory properties that may contribute to therapeutic effects. Third, nano- and microgels for systemic delivery are examined. These include polymer-based nanogels with stimuli-responsive drug release responding to oxidative stress, pH changes, and enzymatic activity characteristic of atherosclerotic lesions. Inorganic–organic composite nanogels incorporating paramagnetic contrast agents enable theranostic applications by combining therapy with imaging-guided treatment monitoring. Current challenges include manufacturing consistency, mechanical stability under physiological flow, long-term safety assessment, and regulatory pathway definition. Future opportunities are discussed in multi-functional integration, artificial intelligence-guided design, personalized formulations, and biomimetic approaches. Gel technologies demonstrate substantial potential to advance atherosclerosis management through improved spatial and temporal control over therapeutic interventions. Full article

In this study, core–shell Ln₂O₃@carbon nanoparticles (core = Ln₂O₃ and shell = carbon; Ln = Tb and Ho) were synthesized for the first time by preparing Ln₂O₃ nanoparticles through a polyol method, followed by carbon coating using D-glucose as a carbon precursor in aqueous media. The synthesized Ln₂O₃@carbon nanoparticles exhibited good colloidal stability in solution and very low toxicity in in vitro cellular cytotoxicity tests. They exhibited paramagnetic magnetization values that increased with increasing applied field strength, resulting from spin–orbit magnetic moments of 4f-electrons; hence, they yielded negligible r₁ (<0.1 s⁻¹mM⁻¹) and appreciable r₂ values (3.446 and 3.677 s⁻¹mM⁻¹ for Ln = Tb and Ho, respectively) at 3 T, highlighting their potential as T₂ MRI contrast agents, particularly at high MR fields. In addition, the carbon coating shell exhibited photoluminescence at 460 nm, suitable for applications in fluorescence imaging probes. Full article

Among the many nanomaterials studied for biomedical uses, silica and gold nanoparticles have gained significant attention because of their unique physical and chemical properties and their compatibility with living tissues. Mesoporous silica nanoparticles (MSNs) have great stability and a large surface area, while gold nanoparticles (AuNPs) display remarkable optical features. Both types of nanoparticles have been widely researched for their individual roles in drug delivery, imaging, biosensing, and therapy. When combined with gadolinium (Gd), a common contrast agent, these nanostructures provide improved imaging due to gadolinium’s strong paramagnetic properties. This study focuses on incorporating gold nanoparticles and gadolinium into a silica matrix to develop a theranostic system. Various analytical techniques were used to characterize the nanocomposites, including infrared spectroscopy (FTIR), ultraviolet-visible spectroscopy (UV-Vis), thermogravimetric analysis (TGA), nitrogen adsorption, scanning electron microscopy (SEM), dynamic light scattering (DLS), X-ray fluorescence (XRF), X-ray diffraction (XRD), vibrating sample magnetometry (VSM), and neutron activation analysis (NAA). Techniques like XRF mapping, XANES, nitrogen adsorption, SEM, and VSM were crucial in confirming the presence of gadolinium and gold within the silica network. VSM and EPR analyses confirmed the attenuation of the saturation magnetization for all nanocomposites. This validates their potential for biomedical applications in diagnostics. Moreover, activating gold nanoparticles in a nuclear reactor generated a promising radioisotope for cancer treatment. These results indicate the potential of using a theranostic nanoplatform that employs mesoporous silica as a carrier, gold nanoparticles for radioisotopes, and gadolinium for imaging purposes. Full article

Iron(III) (Fe(III)) complexes have recently emerged as safer alternatives to magnetic resonance imaging (MRI) contrast agents (CAs), reigniting interest in biomedical research. Although gadolinium Gd(III)-based contrast agents (CAs) have been widely used in MRI over the past four decades, their use in the current clinical routine is severely constrained due to concerns about high toxicity and environmental impact. Research is now focusing on synthesizing safer contrast agents with alternative paramagnetic ions like Fe(III) or Mn(II). MRI CAs with integrated potent therapeutic moieties may offer synergistic advantages over traditional contrast agents in clinical use. The study explored the use of salinomycin-ferrihydrite composites as possible effective ensembles of imaging and therapeutic units in the same molecule, evaluating their anticancer activity and influence on the signal in MRI. The composites were characterized using Mössbauer spectroscopy and ICP-MS for iron content determination. The in vitro relaxivity measurements in a high-field MR scanner demonstrated the potency of the composites as T₂ enhancers. The antitumor activity of one selected Sal-ferrihydrite composite was tested in three human cancer cell lines: A549 (non-small cell lung cancer); SW480 (colon cancer); and CH1/PA1 (ovarian teratocarcinoma) by the MTT cell viability assay. The new Sal-ferrihydrite composite showed a pronounced cytotoxicity in all three human cancers in line with enhanced signal in MRI, which makes it a promising candidate for future biomedical applications. The superior cytotoxic effect, together with the strong signal enhancement, makes these compounds promising candidates for further detailed investigations as future theranostic agents. Full article

Synthesized Ln₂O₃ (Ln = La, Nd or Gd) nanoparticles with sizes of 1–3 nm, 5–6 nm and 10–15 nm were stabilized by carbon nanoflakes (CNFs). The weight content of Ln₂O₃ in the Ln₂O₃/CNF composites was 20–50 wt. %, which makes these composites potentially suitable for practical use as computed tomography and magnetic resonance imaging contrast agents. The structure of CNFs and Ln₂O₃/CNF composites was investigated by X-ray diffraction data, X-ray photoelectron spectroscopy (XPS) and electron paramagnetic resonance (EPR). The EPR spectra of raw CNFs were silent. The oxidation of the CNF surface resulted in the appearance of paramagnetic centers associated with two types of unpaired electrons in the carbon support. After impregnation of the CNFs with the Ln³⁺ ion solution, the number of unpaired electrons was reduced, presumably due to the formation of C–O–Ln bonds. All Ln³⁺ ions changed the composites’ EPR spectra by reducing the number of unpaired electrons in the CNF structure. Full article

Gadolinium-based contrast agents (GBCAs) are the gold standard as MRI probes but are nowadays facing medical limitations and environmental concerns. To address these issues, novel strategies focus on the optimization of Gd(III)-based probes. One promising approach involves incorporating Gd(III) into nanoparticles, particularly coordination polymers, which offer improved relaxivity. In this study, we explore the self-assembly of Gd(III) ions with ascorbate ligand, forming extended coordination polymer architectures. Our investigation focuses on understanding the impact of nanoparticles’ growth and aggregation on their relaxivity properties. Notably, the controlled aggregation process leads to a different distribution of the Gd(III) in the surface and in the bulk of the nanoparticles, mainly responsible for their longitudinal relaxivity. Additionally, the introduction of Eu(III) into the network enables the development of a dual-modal probe with paramagnetic and optical features. Full article

The present study introduces a novel theranostic nanoparticle platform that integrates superparamagnetic iron oxide nanoparticles (SPIONs) with a ferritin-based protein nanocage derived from the archaeobacterium Archaeoglobus fulgidus. By exploiting the unique salt-triggered dissociation and reassociation mechanism of the nanocage, SPIONs were successfully encapsulated within the protein’s central cavity. The construct thus obtained was characterized by transmission electron microscopy and circular dichroism spectroscopy. The ferritin-coated SPIONs exhibited remarkable superparamagnetic behavior and robust magnetic properties. Characterization using electron paramagnetic resonance and thermal magnetization analysis confirmed the stability of the nanoparticles and their suitability for magnetic hyperthermia applications. Furthermore, T₂-weighted magnetic resonance imaging (MRI) demonstrated enhanced contrast, with ferritin-coated SPIONs generating distinct dark-spot imaging, highlighting their efficacy as a contrast agent for advanced biomedical applications. Full article

We report two conjugates of gem-diethyl pyrroline nitroxide radicals with D-mannosamine as potential metabolic organic radical contrast agents, mORCAs, circumventing the need for biorthogonal reactions. In-cell EPR spectroscopy, using Jurkat cells and analogous conjugate, based on a pyrrolidine nitroxide radical, shows an efficient incorporation of highly immobilized nitroxides, with a correlation time of τ_cor = 20 ns. In vivo MRI experiments in mice show that the paramagnetic nitroxide radical shortens the T₁ and T₂ relaxation times of protons in water located in the kidney and brain by only up to ~10% after 3 d. Ex vivo EPR spectroscopic analyses indicate that the contrast agents in mouse tissues are primarily localized in the kidney, lung, liver, heart, and blood, which primarily contain immobilized nitroxide radicals with τ_cor = 4–9 ns. The spin concentrations in tissues remain low (1–3 nmol g⁻¹) at 24 h after the third mORCA injection, approximately one to two orders of magnitude lower than those of ORCAFluor and BASP-ORCA (measured at ~24 h post-injection). These low spin concentrations explain the small proton T₁ and T₂ relaxation changes observed in in vivo MRI. Full article

Grafting of paramagnetic transition and rare earth metal ions onto the surface of detonation nanodiamonds (DNDs) was successfully implemented in the recent decade and opened new opportunities in the biomedical application of these compounds, particularly as novel contrast agents for magnetic resonance imaging. The grafting was studied mainly using EPR, NMR, and magnetic measurements. Such a highly surface-sensitive, quantitative, chemical analytic technique as X-ray photoelectron spectroscopy (XPS) was very rarely used. In this paper, we report the XPS study of grafting transition and rare-earth metal ions (Cu²⁺, Co²⁺, Mn²⁺, and Gd³⁺) onto the surface of DNDs. Binding energies for metal, carbon, oxygen, and nitrogen atoms were determined and attributed to the corresponding ion states and atomic groups. Comparing XPS and EPR findings, we showed that the developed synthesis route resulted in almost complete grafting of manganese and gadolinium atoms in the form of paramagnetic ions Mn²⁺ and Gd³⁺ to the diamond surface, while only 30% of the copper atoms on the surface are in the paramagnetic state Cu²⁺, and the rest 70% are in the non-magnetic Cu⁺ state. It was not possible to draw a similar conclusion regarding Co²⁺ ions due to the lack of data on the amount of these paramagnetic ions on the DND surface. Full article